Information about COVID-19
Keeping people with epilepsy safe during the Covid-19 pandemic
French et al, Neurology, April 2020
COVID-19 and Epilepsy: More resources from ILAE for patients, clinicians and researchers
Dia Internacional de la epilepsia
Dia Internacional de la epilepsia 2021 (Mario A. Alonso Vanegas)
Hoy 8 de febrero de 2021 es un día muy especial para todas las personas que formamos parte de esta comunidad asistencial, scientífica y social. Tras estos meses de pandemia que han desgastado a la humanidad es grato estar hoy presente para unir juntos la voz, la voz de la esperanza. Personalmente es un día y un tiempo muy importante al ser el primer año del periodo que estaré como presidente de la Comisión de Asuntos Latinoamericanos de la ILAE, nos esperan momentos de mucho trabajo y unión para continuar en el camino de la lucha para sacar la epilepsia de las sombras.
The ILAE - Latin America region comprises South and Middle America and Mexico where Spanish and Portuguese are the main languages spoken. Within the framework and according to the strategic plan of the central ILAE, the goal of the ILAE-Latin America is to serve as a regional resource for current and emerging knowledge on epilepsy prevention, diagnosis, treatment, and research.
Current efforts of the ILAE-Latin America are focused on the development of national epilepsy programs and laws and telemedicine projects in the region. In the field of education, courses are being organized for the primary health level as well as specialized epilepsy care.
As the region is extremely heterogeneous, an effort is being made to provide equal learning opportunities for health professionals in rich and poor countries and areas. Guidelines and seminal scientific articles that are available only in English are being translated into Spanish and Portuguese to increase access to knowledge.
Latinoamerica presente en las premiaciones del 33avo Congreso International de Epilepsia
Latin American Awards at the 33rd International Epilepsy Congress
Elections for ALADE
ILAE-Latin America announces the new members of the ALADE Task Force, effective April 2019. See Commission and Task Force Members.
Applications are now being accepted for funds for a two year research project aimed at understanding the pathogenesis of Dravet syndrome and paving the way to new treatments.
19 January, 2021
This article examines the potential impact of FUS (Focused ultrasound) on the landscape of brain therapies as well as the challenges facing further advancement and broader adoption of this promising minimally invasive therapeutic alternative.
7 January, 2021
From Monday, January 4th to International Epilepsy Day – Monday February 8th, the International Bureau for Epilepsy encourages everyone to walk to raise awareness, improve visibility, and to increase understanding of epilepsy.
4 January, 2021
The anti-seizure medications used to treat patients with epilepsy can improve symptoms but do not address the underlying cause of the condition. In this Review, the authors discuss the ongoing shift towards personalized treatments for specific epilepsy aetiologies.
1 December, 2020
These results provide support for the importance of medication adherence and intensified AED treatment for patients with poorly controlled GTCS in the effort to reduce SUDEP risk and suggest that comedication with statins may reduce risk.
4 November, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community